Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Sagimet Biosciences Inc. (SGMT) had Current Assets of $152.77M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-45.57M |
|
-- |
|
-- |
|
$54.45M |
|
$-54.45M |
|
$8.89M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-45.57M |
|
$-54.45M |
|
$-55.71M |
|
31.35M |
|
31.35M |
|
$-1.45 |
|
$-1.45 |
|
| Balance Sheet Financials | |
|
Current Assets |
$152.77M |
-- |
|
$7.49M |
|
$160.26M |
|
$4.45M |
|
-- |
|
-- |
|
$4.45M |
|
$155.81M |
|
$155.81M |
|
$155.81M |
|
32.20M |
|
| Cash Flow Statement Financials | |
$-42.44M |
|
$-61.68M |
|
$104.82M |
|
$75.14M |
|
$75.84M |
|
$0.70M |
|
$5.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
34.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-42.44M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.25% |
|
-29.25% |
|
-28.43% |
|
-29.25% |
|
$4.84 |
|
$-1.35 |
|
$-1.35 |
|